- Previous Rank403
- Revenues ($M)$28,401
- Revenue Percent Change5.3%
- Profits ($M)$184.4
- Profits Percent Change36.1%
- Assets ($M)$10,410.00
- Employees27,638
Company Information
Figures prepared in accordance with International Accounting Standards., Figures are for fiscal year ended Jan. 31, 2018., Reorganized as a new holding company, Oct. 18, 2017.
| CEO | Oliver Windholz |
| Sector | Wholesalers |
| Industry | Wholesalers: Health Care |
| HQ Location | Mannheim, Germany |
| Website | http://www.phoenixgroup.eu |
| Years on Global 500 List | 8 |
| Employees | 27,638 |
Phoenix Pharma Rank History
placeholder
Key Financials (Last Fiscal Year)
| ($ Millions) | % change | |
|---|---|---|
| Revenues ($M) | $28,401 | 5.3% |
| Profits ($M) | $184.4 | 36.1% |
| Assets ($M) | $10,410.00 | - |
| Total Stockholder Equity ($M) | $2,993.90 | - |
Profit Ratios
| Profit as % of Revenues | 0.6% |
| Profits as % of Assets | 1.8% |
| Profits as % of Stockholder Equity | 6.2% |